I have found a lot of things to be optimistic about with respect to the Verastem (NASDAQ: VSTM ) investment thesis in past articles, including my most recent one focusingI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do your due diligence and not get burned by the pitfalls of investing in this space.Analyst’s Disclosur ...